Cannabis advocates and researchers have long touted the benefits of using cannabidiol (CBD) for the medical treatment of things like anxiety, epilepsy, insomnia, and pain. Now, thanks to a growing interest in alternative medical treatments and increasing acceptance from government bodies around the world, companies like StillCanna (CSE:STIL) (OTCPK:SCNNF) are able to offer high-quality CBD oil to people in need.
StillCanna (CSE:STIL) (OTCPK:SCNNF) is an early-stage life sciences company that is focused on large-scale CBD extraction in Europe. In May, Dr. Brian Martin joined the StillCanna team as its VP of product development.
...Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.